Assessment of treatment-seeking behavior and healthcare utilization in an international cohort of subjects with overactive bladder

被引:9
|
作者
Jimenez-Cidre, Miguel [1 ]
Costa, Pierre [2 ]
Ng-Mak, Daisy [3 ]
Sahai, Arun [4 ]
Degboe, Arnold [3 ]
Smith, Christopher Patrick [5 ]
Tsai, Kathleen [3 ,6 ]
Herschorn, Sender [7 ]
机构
[1] Hosp Univ Ramon & Cajal, Madrid 28034, Spain
[2] Univ Montpellier I, Acad Hosp Caremau, Urol & Androl Dept, Nimes, France
[3] Allergan Pharmaceut Inc, Irvine, CA USA
[4] Guys Hosp, Dept Urol, London SE1 9RT, England
[5] Baylor Coll Med, Houston, TX 77030 USA
[6] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA
[7] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
关键词
Burden of incontinence; Healthcare resource utilization; Incontinence severity; Overactive bladder; Treatment-seeking behavior; Urinary incontinence; Urinary symptoms; QUALITY-OF-LIFE; URINARY-TRACT SYMPTOMS; WORK PRODUCTIVITY; INCONTINENCE; IMPACT; PREVALENCE; COSTS; WOMEN;
D O I
10.1185/03007995.2014.918028
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To assess the association between incontinence severity, treatment-seeking behavior, and healthcare resource utilization (HRU) among participants with overactive bladder (DAB) in eight countries. Research design and methods: A cross-sectional online survey of subjects >= 18 years old in Australia, Europe, and North America, who had a past DAB diagnosis and/or experienced >= 1 urinary incontinence (UI) episode in the preceding 12 months, were eligible to participate. Subjects contacted for the survey were primarily from a voluntary medication monitoring registry, MediGuard. Predominantly stress incontinence subjects were excluded. Incontinence severity was assessed by the number of UI episodes over 3 days and grouped as 0 ('dry'), 1-2, 3-4, and >= 5 UI episodes/day. Subject demographics, employment status, comorbidities, treatment-seeking behavior (past DAB diagnosis; spoken to healthcare provider [HCP), and HRU (diagnostic tests; HCP visits in 6 months before screening) were analyzed by incontinence severity. Results: Overall, 1341 subjects with DAB (mean age 54.5 years; 70.7% female) were surveyed; 20.2%, 47.7%, 18.8%, and 13.3% of subjects reported 0, 1-2, 3-4, and >= 5 UI episodes/day, respectively. Employment status and comorbidities were significantly (p< 0.05) associated with incontinence severity. The two measures of treatment-seeking behavior were significantly (p< 0.05) associated with incontinence severity groups; the proportion of subjects with a past diagnosis of DAB were 35.8%, 44.8%, 52.4%, and 64.0% in the 0, 1-2, 3-4, and >= 5 UI episodes/day groups, respectively; and 59.0%, 63.6%, 65.9%, and 78.1% of subjects in the respective UI severity groups talked to a HCP about their DAB symptoms. Multivariate linear regression analyses showed a positive and consistent association between incontinence severity and HRU; subjects reported a mean of 2.7, 4.1, 4.4, and 7.7 diagnostic tests overall (p< 0.001), and a mean of 1.4, 2.2, 2.7, and 4.0 HCP visits in the 0, 1-2, 3-4, and >= 5 UI episodes/day groups, respectively (p< 0.001). A potential limitation of the study is the cross-sectional survey methodology which limits the ability to draw causal inferences from the results. Additionally, since this is a web-based survey it is possible respondents who have access to/are familiar with technology were more likely to be enrolled. Conclusions: Incontinence severity was positively associated with both treatment-seeking behavior and HRU among subjects with DAB.
引用
收藏
页码:1557 / 1564
页数:8
相关论文
共 50 条
  • [41] Re: Anticholinergic Burden and Associated Healthcare Resource Utilization in Older Adults with Overactive Bladder
    Griebling, Tomas L.
    [J]. JOURNAL OF UROLOGY, 2022, 208 (02): : 453 - 454
  • [42] COMPARISON OF HEALTHCARE COSTS AND RESOURCE UTILIZATION FOR OVERACTIVE BLADDER PATIENTS IN THE UNITED STATES PERSISTING WITH MIRABEGRON TREATMENT OR SWITCHING TO ONABOTULINUMTOXINA
    Ng, D. B.
    Espinosa, R.
    Johnson, S.
    Walker, D.
    Gooch, K.
    [J]. NEUROUROLOGY AND URODYNAMICS, 2017, 36 : S362 - S363
  • [43] Eating behaviour in treatment-seeking obese subjects - Influence of sex and BMI classes
    Ernst, Barbara
    Wilms, Britta
    Thurnheer, Martin
    Schultes, Bernd
    [J]. APPETITE, 2015, 95 : 96 - 100
  • [44] Health Seeking Behaviour and Healthcare Utilization in a Rural Cohort of North India
    Yadav, Rajaram
    Zaman, Kamran
    Mishra, Ayush
    Reddy, Mahendra M.
    Shankar, Prem
    Yadav, Priyanka
    Kumar, Kaushik
    Kant, Rajni
    [J]. HEALTHCARE, 2022, 10 (05)
  • [45] Dengue Treatment-Seeking Behavior: A Qualitative Study With Costa Rican Residents
    Le, Alexander
    Ali, Sara
    Blackburn, Christine C.
    Ruyle, Leslie
    Hernandez, Jessica
    Abarca, Farid
    Arroniz, Araceli
    Rivera, Sanny
    Jerman, Kaylee
    Kashyap, Neha
    Davila, Edward
    Ortega, Kathryn
    Zavala, Yesenia
    [J]. HEALTH EDUCATION & BEHAVIOR, 2024,
  • [46] Predictors to treatment-seeking behavior in Latino parents of children with ADHD symptoms
    Fernandez, Alexandra Ramos
    Velez-Pastrana, Maria C.
    [J]. INTERNATIONAL JOURNAL OF PSYCHOLOGY, 2023, 58 : 109 - 109
  • [47] Annual Costs Associated with Patients with Migraine by Intensity of Treatment-Seeking Behavior
    Horbyuk, Ruslan
    Tran, Oth
    Chan, Philip
    Kim, Gilwan
    Smith, David
    Patel, Chad
    [J]. NEUROLOGY, 2020, 94 (15)
  • [48] Treatment-seeking behavior of US women with hypoactive sexual desire disorder
    Shiften, Jan L.
    Clayton, Anita H.
    Monz, Brigitta
    Russo, Patricia
    Beinett, Lee
    Johannes, Catherine B.
    [J]. OBSTETRICS AND GYNECOLOGY, 2008, 111 (04): : 17S - 17S
  • [49] TREATMENT-SEEKING BEHAVIOR AMONG UNIVERSITY STUDENTS REPORTING PAIN AND DEPRESSION
    Zhang, Y.
    Shah, D.
    Fiano, R.
    Dwibedi, N.
    [J]. VALUE IN HEALTH, 2019, 22 : S231 - S232
  • [50] Treatment-seeking behavior in Hong Kong Chinese women with urinary symptoms
    S.-K. Yip
    T.K.-H. Chung
    [J]. International Urogynecology Journal, 2003, 14 : 27 - 30